Business
Director/PDMR and PCA Shareholding
On September 24, 2025, Chris Meredith, a Director and PDMR of Advanced Medical Solutions Group plc, executed a series of share transfers as part of tax planning. A total of 50,510 ordinary shares of 5p, previously held in the name of Platform Securities Nominees Limited, were sold at a price of 218.5p per share. Subsequently, 9,934 shares were purchased into Individual Savings Accounts (ISAs) held by Chris Meredith, 9,932 shares into ISAs held by Ingrid Meredith, 2,257 shares into Chris Meredith's Self-Invested Personal Pensions (SIPPs), and 1,300 shares into Ingrid Meredith's SIPPs, all at 218.54p per share. The transactions, executed on the London Stock Exchange AIM Market, did not alter the overall beneficial ownership of shares held by Chris Meredith, Ingrid Meredith, and their related parties. Disclaimer*
About this update from Advanced Medical Solutions Group Plc
[{"type":"text","content":"\n\n\n\n\n\n \n\n\n25 September 2025\n\n\n\n\n Advanced Medical Solutions Group plc\n(\"AMS\", the \"Company\" or the \"Group\")\n \n Director/PDMR and PCA Shareholding\n \nWinsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, announces that it was notified on 24 September 2025 that on the same day Chris Meredith, who is a Director and PDMR, transferred, through sale and repurchase, a total of 50,510 Ordinary Shares of 5p held on his behalf held in the name of Platform Securities Nominees Limited (\"Nominee\"), at a sale price of 218.5p per Ordinary Share to (i) a combination of Individual Savings Accounts (\"ISA's\") and Self-Invested Personal Pensions (SIPP's) held in the name of Chris Meredith and Ingrid Meredith; and (ii) his adult Children, all at a price of 218.54p per Ordinary Share.\n \nThe number of shares, and the beneficial ownership of the shares, held by Chris Meredith, Ingrid Meredith and his PCA's remains unchanged. These transactions are part of normalised tax planning.\n \nThe notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.\n \n\n\n\n\n1.\n\n\nDetails of the person discharging managerial responsibilities/person closely associated\n\n\n\n\na)\n\n\nName:\n(i) Chris Meredith\n(ii) Ingrid Meredith\n\n\n\n\n2.\n\n\nReason for the notification\n\n\n\n\na)\n\n\nPosition/status:\n(i) Chief Executive Officer\n(ii) Wife of Chris Meredith\n\n\n\n\nb)\n\n\nInitial notification/Amendment: Initial Notification\n\n\n\n\n3.\n\n\nDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor\n\n\n\n\na)\n\n\nName: Advanced Medical Solutions Group plc\n\n\n\n\nb)\n\n\nLEI: 213800HJP6OWOSZI1L74\n\n\n\n\n4.\n\n\nDetails of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\n\n\n\n\na)\n\n\nDescription of the financial instrument, type of instrument: Ordinary Shares of 5p\nIdentification...